Trial intelligence / Profile preview

Effect of drospirenone on apoptosis and anti-proliferation in ectopic endometrial stromal cells

TCTR20221129005Phase 2Unknown

Sponsor
Siriraj Research Development Fund
Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of drospirenone in endometriosis, sponsored by Siriraj Research Development Fund. Status: unknown.

02

Drugs

drospirenone
03

Conditions

endometriosis

Beyond the preview

Go deeper on TCTR20221129005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20221129005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call